![4-acetoxy DMT (fumarate) (4-acetoxy-N,N-Dimethyltryptamine, O-Acetylpsilocin, Psilacetin, CAS Number: 1217230-42-6) | Cayman Chemical 4-acetoxy DMT (fumarate) (4-acetoxy-N,N-Dimethyltryptamine, O-Acetylpsilocin, Psilacetin, CAS Number: 1217230-42-6) | Cayman Chemical](https://cdn2.caymanchem.com/cdn/productImages/35188.png)
4-acetoxy DMT (fumarate) (4-acetoxy-N,N-Dimethyltryptamine, O-Acetylpsilocin, Psilacetin, CAS Number: 1217230-42-6) | Cayman Chemical
![Active Metabolite of Aeruginascin (4-Hydroxy-N,N,N-trimethyltryptamine): Synthesis, Structure, and Serotonergic Binding Affinity | ACS Omega Active Metabolite of Aeruginascin (4-Hydroxy-N,N,N-trimethyltryptamine): Synthesis, Structure, and Serotonergic Binding Affinity | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.0c02208/asset/images/medium/ao0c02208_0001.gif)
Active Metabolite of Aeruginascin (4-Hydroxy-N,N,N-trimethyltryptamine): Synthesis, Structure, and Serotonergic Binding Affinity | ACS Omega
![Frontiers | Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders Frontiers | Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders](https://www.frontiersin.org/files/Articles/927984/fphar-13-927984-HTML/image_m/fphar-13-927984-g001.jpg)
Frontiers | Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders
![Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis | SpringerLink Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40429-021-00385-5/MediaObjects/40429_2021_385_Fig1_HTML.png)
Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis | SpringerLink
![Investigation of the Structure-Activity Relationships of Psilocybin Analogues. - Abstract - Europe PMC Investigation of the Structure-Activity Relationships of Psilocybin Analogues. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8033608/bin/pt0c00176_0001.jpg)
Investigation of the Structure-Activity Relationships of Psilocybin Analogues. - Abstract - Europe PMC
![JoX | Free Full-Text | Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective? JoX | Free Full-Text | Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?](https://pub.mdpi-res.com/jox/jox-12-00004/article_deploy/html/images/jox-12-00004-g002.png?1644221985)
JoX | Free Full-Text | Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?
![A single administration of the hallucinogen, 4‐acetoxy‐dimethyltryptamine, prevents the shift to a drug‐dependent state and the expression of withdrawal aversions in rodents - Vargas‐Perez - 2017 - European Journal of Neuroscience - A single administration of the hallucinogen, 4‐acetoxy‐dimethyltryptamine, prevents the shift to a drug‐dependent state and the expression of withdrawal aversions in rodents - Vargas‐Perez - 2017 - European Journal of Neuroscience -](https://onlinelibrary.wiley.com/cms/asset/1922c15e-e0b3-4f9a-9fbe-0c8e2c2d2b77/ejn13572-fig-0002-m.jpg)